165 related articles for article (PubMed ID: 38473941)
21. SOX2 expression in hypopharyngeal, laryngeal, and sinonasal squamous cell carcinoma.
González-Márquez R; Llorente JL; Rodrigo JP; García-Pedrero JM; Álvarez-Marcos C; Suárez C; Hermsen MA
Hum Pathol; 2014 Apr; 45(4):851-7. PubMed ID: 24656096
[TBL] [Abstract][Full Text] [Related]
22. PIK3CA gene amplification and PI3K p110α protein expression in breast carcinoma.
Firoozinia M; Zareian Jahromi M; Moghadamtousi SZ; Nikzad S; Abdul Kadir H
Int J Med Sci; 2014; 11(6):620-5. PubMed ID: 24782652
[TBL] [Abstract][Full Text] [Related]
23. SOX2 expression and prognostic significance in ovarian carcinoma.
Pham DL; Scheble V; Bareiss P; Fischer A; Beschorner C; Adam A; Bachmann C; Neubauer H; Boesmueller H; Kanz L; Wallwiener D; Fend F; Lengerke C; Perner S; Fehm T; Staebler A
Int J Gynecol Pathol; 2013 Jul; 32(4):358-67. PubMed ID: 23722508
[TBL] [Abstract][Full Text] [Related]
24. A simple specific pattern of chromosomal aberrations at early stages of head and neck squamous cell carcinomas: PIK3CA but not p63 gene as a likely target of 3q26-qter gains.
Redon R; Muller D; Caulee K; Wanherdrick K; Abecassis J; du Manoir S
Cancer Res; 2001 May; 61(10):4122-9. PubMed ID: 11358835
[TBL] [Abstract][Full Text] [Related]
25. GATA binding protein 6 (GATA6) is co-amplified with PIK3CA in patients with esophageal adenocarcinoma and is linked to neoadjuvant therapy.
Plum PS; Löser H; Zander T; Essakly A; Bruns CJ; Hillmer AM; Alakus H; Schröder W; Büttner R; Gebauer F; Quaas A
J Cancer Res Clin Oncol; 2021 Apr; 147(4):1031-1040. PubMed ID: 33300112
[TBL] [Abstract][Full Text] [Related]
26. Sex-determining region Y-box 2 amplification in preneoplastic squamous lesions of the lung.
Schneider F; Luvison A; Cieply K; Dacic S
Hum Pathol; 2013 May; 44(5):706-11. PubMed ID: 23159246
[TBL] [Abstract][Full Text] [Related]
27. Copy number gain of PIK3CA and MET is associated with poor prognosis in head and neck squamous cell carcinoma.
Brauswetter D; Dános K; Gurbi B; Félegyházi ÉF; Birtalan E; Meggyesházi N; Krenács T; Tamás L; Peták I
Virchows Arch; 2016 May; 468(5):579-87. PubMed ID: 26832731
[TBL] [Abstract][Full Text] [Related]
28. Prognostic role of PIK3CA and TP53 in human papillomavirus-negative oropharyngeal cancers.
Resteghini C; Perrone F; Miceli R; Bergamini C; Alfieri S; Orlandi E; Guzzo M; Granata R; Galbiati D; Cavalieri S; Locati L; Licitra L; Bossi P
Tumori; 2018 Jun; 104(3):213-220. PubMed ID: 29714670
[TBL] [Abstract][Full Text] [Related]
29. SOX2 Gene Amplification and Overexpression is Linked to HPV-positive Vulvar Carcinomas.
Gut A; Moch H; Choschzick M
Int J Gynecol Pathol; 2018 Jan; 37(1):68-73. PubMed ID: 28700423
[TBL] [Abstract][Full Text] [Related]
30. PIK3CA amplification is associated with poor prognosis among patients with curatively resected esophageal squamous cell carcinoma.
Kim HS; Lee SE; Bae YS; Kim DJ; Lee CG; Hur J; Chung H; Park JC; Shin SK; Lee SK; Lee YC; Kim HR; Shim YM; Jewell SS; Kim H; Choi YL; Cho BC
Oncotarget; 2016 May; 7(21):30691-701. PubMed ID: 27095573
[TBL] [Abstract][Full Text] [Related]
31. Expression of the embryonic stem cell marker SOX2 in early-stage breast carcinoma.
Lengerke C; Fehm T; Kurth R; Neubauer H; Scheble V; Müller F; Schneider F; Petersen K; Wallwiener D; Kanz L; Fend F; Perner S; Bareiss PM; Staebler A
BMC Cancer; 2011 Jan; 11():42. PubMed ID: 21276239
[TBL] [Abstract][Full Text] [Related]
32. The chromosome 3q26 OncCassette: A multigenic driver of human cancer.
Fields AP; Justilien V; Murray NR
Adv Biol Regul; 2016 Jan; 60():47-63. PubMed ID: 26754874
[TBL] [Abstract][Full Text] [Related]
33. Highly frequent PIK3CA amplification is associated with poor prognosis in gastric cancer.
Shi J; Yao D; Liu W; Wang N; Lv H; Zhang G; Ji M; Xu L; He N; Shi B; Hou P
BMC Cancer; 2012 Feb; 12():50. PubMed ID: 22292935
[TBL] [Abstract][Full Text] [Related]
34. PIK3CA Amplification Is Common in Left Side-Tubular Adenomas but Uncommon Sessile Serrated Adenomas Exclusively with KRAS Mutation.
Lee H; Lee JH; Kim DK; Choi IJ; Hwang I; Kang YN; Kim S
Int J Med Sci; 2015; 12(4):349-53. PubMed ID: 26019684
[TBL] [Abstract][Full Text] [Related]
35. Sequence mutations and amplification of PIK3CA and AKT2 genes in purified ovarian serous neoplasms.
Nakayama K; Nakayama N; Kurman RJ; Cope L; Pohl G; Samuels Y; Velculescu VE; Wang TL; Shih IeM
Cancer Biol Ther; 2006 Jul; 5(7):779-85. PubMed ID: 16721043
[TBL] [Abstract][Full Text] [Related]
36. Concomitant PIK3CA amplification and RASSF1A or PAX6 hypermethylation predict worse survival in gastric cancer.
Yang Q; Shao Y; Shi J; Qu Y; Wu K; Dang S; Shi B; Hou P
Clin Biochem; 2014 Jan; 47(1-2):111-6. PubMed ID: 24505629
[TBL] [Abstract][Full Text] [Related]
37. Role of HERG1 potassium channel in both malignant transformation and disease progression in head and neck carcinomas.
Menéndez ST; Rodrigo JP; Alvarez-Teijeiro S; Villaronga MÁ; Allonca E; Vallina A; Astudillo A; Barros F; Suárez C; García-Pedrero JM
Mod Pathol; 2012 Aug; 25(8):1069-78. PubMed ID: 22460808
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of PIK3CA in head and neck squamous cell carcinoma is associated with poor outcome and activation of the YAP pathway.
García-Escudero R; Segrelles C; Dueñas M; Pombo M; Ballestín C; Alonso-Riaño M; Nenclares P; Álvarez-Rodríguez R; Sánchez-Aniceto G; Ruíz-Alonso A; López-Cedrún JL; Paramio JM; Lorz C
Oral Oncol; 2018 Apr; 79():55-63. PubMed ID: 29598951
[TBL] [Abstract][Full Text] [Related]
39. Clinical-Pathologic Analysis of Breast Cancer With PIK3CA Mutations in Chinese Women.
Lian J; Xu EW; Xi YF; Wang HW; Bu P; Wang JF; Wang LX
Technol Cancer Res Treat; 2020; 19():1533033820950832. PubMed ID: 33047659
[TBL] [Abstract][Full Text] [Related]
40. Single nucleotide polymorphism rs17849071 G/T in the PIK3CA gene is inversely associated with follicular thyroid cancer and PIK3CA amplification.
Xing JC; Tufano RP; Murugan AK; Liu D; Wand G; Ladenson PW; Xing M; Trink B
PLoS One; 2012; 7(11):e49192. PubMed ID: 23185308
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]